Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Xu C, Shao Y, Xia T, Yang Y, Dai J, Luo L, Zhang X, Sun W, Song H, Xiao B. lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35(10):9701–6.
Zhu S, Weng J, Zhu HY. Study on the prokaryotic expression of human papillomavirus type16 E7 protein and its role in cervical cancer treatment. Mod Prev Med. 2009;36(22):4317.
Jun-Qi M, Hatila T, Shu-Juan J, Jian-He Z, Jing-Bao X, Ayshamgul H. Functional Role of NRF2 in Cervical Carcinogenesis. PLoS One. 2015;10(8):e0133876.
Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15(6):362–74.
Chen G, Cheng X, Zhao M, Lin S, Lu J, Kang J, Yu X. RIP1-dependent bid cleavage mediates TNFα-induced but Caspase-3-independent cell death in L929 fibroblastoma cells. Apoptosis. 2015;20(1):92–109.
Legarda D, Justus SJ, Ang RL, Rikhi N, Li W, Moran TM, Zhang J, Mizoguchi E, Zelic M, Kelliher MA. CYLD proteolysis protects macrophages from TNF-mediated auto-necroptosis induced by LPS and licensed by type I IFN. Cell Rep. 2016;15(11):2449–61.
Meng MB, Wang HH, Cui YL, Wu ZQ, Shi YY, Zaorsky NG, Deng L, Yuan ZY, Lu Y, Wang P. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. Oncotarget. 2016;7(35):57391–413.
Yang J, Zhao Y, Zhang L, Fan H, Qi C, Zhang K, Liu X, Fei L, Chen S, Wang M. RIPK3/MLKL-Mediated Neuronal Necroptosis Modulates the M1/M2 Polarization of Microglia/Macrophages in the Ischemic Cortex. Cereb Cortex. 2018;28:7.
Ofengeim D, Yuan J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol. 2013;14(11):727–36.
Nault JC, Galle PR, Marquardt JU. The role of molecular enrichment on future therapies in hepatocellular carcinoma. J Hepatol. 2018;69(1):S016882781830134X.
Chae YS, Kim JG, Sang KS, Su JL, Kang BW, Moon JH, Park JY, Jeon SW, Bae HI, Choi GS. RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection. J Cancer Res Clin Oncol. 2011;137(4):705–13.
Kondylis V, Kumari S, Vlantis K, Pasparakis M. The interplay of IKK, NF-κB and RIPK 1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol Rev. 2017;277(1):113–27.
Chae Y, Kim J, Sohn S, Kim S, Lee S, Moon J, Jeon S, Cho Y, Choi G, Jun S. RIPK1 gene polymorphism as a prognostic marker for survival in patients with colorectal cancer. J Clin Oncol. 2009;27(15_suppl):e15078.
Wang J, Chai YL, Wang T, Liu JH, Dai PG, Liu Z. Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy. Exp Mol Pathol. 2015;98(3):407–10.
Dai ZJ, Liu XH, Kang HF, Wang XJ, Jin TB, Zhang SQ, Feng T, Ma XB, Wang M, Feng YJ. Genetic variation in metastasis-associated in Colon Cancer-1 and the risk of breast Cancer among the Chinese Han population: a STROBE-compliant observational study. Medicine. 2016;95(6):e2801.
Zhou L, He N, Feng T, Geng T, Jin T, Chen C. Association of five single nucleotide polymorphisms at 6q25.1 with breast cancer risk in northwestern China. Am J Cancer Res. 2014;5(8):2467.
Xia P, Li B, Geng T, Deng Z, Dang C, Chang D, Kang L, Jin T, Chen C. FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population. Am J Cancer Res. 2015;5(5):1854–61.
Stanger BZ, Leder P, Lee TH, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 1998;81(4):513–23.
Eichholtz-Wirth H, Sagan D. IκB/NF-κB mediated cisplatin resistance in HeLa cells after low-dose γ-irradiation is associated with altered SODD expression. Apoptosis. 2000;5(3):255–63.
Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA. The receptor interacting protein (RIP1) inhibits p53 induction through NF-κB activation and confers a worse prognosis in glioblastoma. Cancer Res. 2009;69(7):2809–16.
Roesler S, Eckhardt I, Wolf S, Fulda S. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells. Oncotarget. 2016;7(4):3709–25.
Qin H, Hua T. Interferon-γ and Smac mimetics synergize to induce apoptosis of lung cancer cells in a TNFα-independent manner. Cancer Cell Int. 2018;18(1):84.
Colbert LH, Hartman TJ, Malila N, Limburg PJ, Pietinen P, Virtamo J, Taylor PR, Albanes D. Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers. Cancer Epidemiol Prev Biomark. 2001;10(3):265–8.
Aamodt R, Jonsdottir K, Andersen SN, Bondi J, Bukholm G, Bukholm IR. Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas. Gastroenterol Res Pract. 2009;2009:1–9.
Seppä K, Pitkäniemi J, Malila N, Hakama M. Age-related incidence of cervical cancer supports two aetiological components: a population-based register study. BJOG Int J Obstet Gynaecol. 2016;123(5):772–8.
Xiong WM, Xu QP, Li X, Xiao RD, Cai L, He F. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget. 2017;8(56):96419–32.